Research in Vermont

Biopharmaceutical research companies are conducting or have conducted more than 560 clinical trials of new medicines in collaboration with the state’s university medical school, clinical research centers and hospitals (1999 to present).

Of the more than 560 clinical trials, 365 target the nation’s six most debilitating chronic diseases— asthma, cancer, diabetes, heart disease, mental illnesses and stroke.

Download PDF